While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the potential to unlock health impact globally.
Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge, so do opportunities in the supply chain.
A federal judge has struck down the $100,000 fee on new H-1B visa holders and invalidated the Sept. proclamation that renewed it.
The rise of generative AI and agentic AI, with AI coding tools capabilities, has created a powerful bear case against traditional software
Vendor pitches and metrics often overlook human acceptance and adaptation when evaluating artificial intelligence.
Amid growing AI doomsday fears, Forrester cuts through the hype with a reality-based view of AI risk, safety, governance, and enterprise priorities.
AI experts debated control, transparency, alignment and auditing as increasingly autonomous agents raise troubling safety concerns.
Lasting growth depends on recognizing when yesterday’s winning strategy has become today’s biggest limitation
Vaibhav Vohra takes over as Epicor CEO on October 1, 2026, as the company moves from its cloud chapter into a broader AI-driven ERP strategy.
AI data centers are powering the artificial intelligence boom, but their rapid expansion is raising concerns about electricity prices, water, health and infrastructure.